Back
Delta Air Lines Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
61
DAL
Delta Air Lines
Last Price:
$47.92
Seasonality Move:
-3.2%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$17.45
Seasonality Move:
2.29%
Buy
61
Delta Air Lines (DAL)
is a Buy
Is Delta Air Lines a Buy, Sell or Hold?
-
The current Delta Air Lines [DAL] share price is $47.92. The Score for DAL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
DAL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.44. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAL Stock Price Chart
What is Delta Air Lines's stock price today?
-
The Delta Air Lines share price today is $47.92The current trend is moderately bullish and DAL is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.
DAL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.01 | Buy |
Relative Strength Index (14 RSI): | 52.56 | Buy |
Chaikin Money Flow: | 4606593 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.94 - 50.1) | Buy |
Bollinger Bands (100): | (43.28 - 63.96) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.67 | Sell |
Relative Strength Index (14 RSI): | 42.89 | Sell |
Chaikin Money Flow: | 20534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.01 - 18.99) | Sell |
Bollinger Bands (100): | (19.23 - 29.65) | Sell |
DAL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.71 | Sell |
20-day SMA: | 47.28 | Buy |
50-day SMA: | 44.65 | Buy |
200-day SMA: | 53 | Sell |
8-day EMA: | 48.99 | Sell |
20-day EMA: | 47.13 | Buy |
50-day EMA: | 38.48 | Buy |
200-day EMA: | 16.5 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.42 | Buy |
20-day SMA: | 18.11 | Sell |
50-day SMA: | 19.97 | Sell |
200-day SMA: | 28.53 | Sell |
8-day EMA: | 17.62 | Sell |
20-day EMA: | 18.04 | Sell |
50-day EMA: | 20.09 | Sell |
200-day EMA: | 28.66 | Sell |
Delta Air Lines Earnings Growth & DAL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $1.10 per share, a decrease this year of $0.63 per share, and an increase next year of $1.30 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Delta Air Lines Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |